Ensign Peak Advisors, Inc Heron Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $429,672 - $867,421	161,531 Added 1150.42%	175,572 $740,000
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $49,539 - $135,480	-21,539 Reduced 60.54%	14,041 $39,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $542,983 - $1.17 Million	-117,275 Reduced 76.72%	35,580 $204,000
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $248,329 - $374,724	29,740 Added 24.16%	152,855 $1.4 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $1.25 Million - $1.85 Million	123,115 New	123,115 $1.32 Million
Q3 2020 Nov 12, 2020	SELL	$13.67 - $17.77 $66,559 - $86,522	-4,869 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$10.23 - $24.56 $60,050 - $144,167	-5,870 Reduced 54.66%	4,869 $57,000
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $187,073 - $285,764	10,739 New	10,739 $253,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.